HuagongsheHuagongshe Chemistry Print Report · For research reference only
Auramycin B → Methyl 2,5,7-trihydroxy-2-methyl-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Auramycin B | HCID 155837 | — |
| Reactant | sulfurmycin B | HCID 155839 | — |
| Product | Methyl 2,5,7-trihydroxy-2-methyl-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate | HCID 174252 | — |
| Product | Sulfurmycin D | HCID 174335 | — |
Reaction Steps
In a manner analogous to that described in Example 22, using a mixture of 200 mg of auramycin B and sulfurmycin B, there were obtained 25 mg of auramycin D and 35 mg of sulfurmycin D.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US04401812 |
| Source dataset | uspto-grants-1983_08 |
| ORD ID | ord-789d8565037b4243a0b2c27579fa798e |
| Source note | uspto-grants-1983_08 |